|
Examination of genomic copy number alterations in renal cell carcinoma with sarcomatoid features. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Endo Pharmaceuticals |
Consulting or Advisory Role - Endo Pharmaceuticals |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - GlaxoSmithKline; Johnson & Johnson |
Consulting or Advisory Role - Myriad Genetics |
Speakers' Bureau - Janssen Oncology |
|
|
No Relationships to Disclose |